Brain: Tumours
(asked on 26th March 2018) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps the Government is taking to (a) increase public awareness of the symptoms of brain tumours and (b) promote early diagnoses of that condition.
There is currently a major £130 million investment in the modernisation of radiotherapy equipment in England. Combined with new approaches to surgery, it is hoped that around 6,000 brain tumour patients a year will benefit from effective but less invasive treatments.
Improving early diagnosis of all cancer is a priority for this Government however we recognise that diagnosis of brain tumours can present certain challenges in general practice. As such, we support the work of HeadSmart in increasing awareness of symptoms that might be brain cancer. As well as making the National Health Service in England aware of the benefits of HeadSmart we have highlighted its benefits with Directors of Public Health, health visitors and school nurses, to encourage their use by professionals in signposting to specialist advice if needed. Further information is available at:
NHS England has confirmed £200 million of transformation funding over the next two years, to encourage local areas to find new and innovative ways to diagnose cancer earlier. NHS England’s Accelerate, Co-ordinate, Evaluate (ACE) programme is testing innovative ways of diagnosing cancer earlier, with ACE Wave 2 piloting multi-disciplinary diagnostic centres for patients with vague or non-specific symptoms, such as brain cancers.
Finally, the government has committed its support to the newly established Less Survivable Cancers Taskforce. The Taskforce is a radical new taskforce representing cancers with stubbornly poor survival rates, specifically lung, liver, brain, oesophageal, pancreatic and stomach cancers. Although cancer survival rates are at an all-time high, these cancers all have a five-year survival rate of less than 20%. The Taskforce calls for the changes required in research, diagnosis, treatment and care to level up the less survivable cancers with those where great progress has been made.